drugset / Trial / NCT01803711
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
RandomizedParallel-groupTriple-blindTreatment
Summary
To assess the efficacy of Omega 3 Fatty acid (Omega 3 FA) augmentation of desvenlafaxine (DVS) compared to placebo augmentation of DVS when used to treat depression and anxiety symptoms in patients with select medical conditions (cancer, cardiovascular diseases and diabetes).
Timeline
- Start
- 2013-02
- Primary completion
- 2016-06
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Desvenlafaxine | Other / unclassified | 50 mg | — |